ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MSYS Microsaic Systems Plc

1.05
0.00 (0.00%)
Last Updated: 08:00:13
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00BMWC8365 ORD GBP0.00001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.05 1.00 1.10 1.05 1.0119 1.05 49,126 08:00:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Components, Nec 1.57M -2.29M -0.0128 -0.82 1.88M
Microsaic Systems Plc is listed in the Electronic Components sector of the London Stock Exchange with ticker MSYS. The last closing price for Microsaic Systems was 1.05p. Over the last year, Microsaic Systems shares have traded in a share price range of 1.00p to 16,406.25p.

Microsaic Systems currently has 179,178,184 shares in issue. The market capitalisation of Microsaic Systems is £1.88 million. Microsaic Systems has a price to earnings ratio (PE ratio) of -0.82.

Microsaic Systems Share Discussion Threads

Showing 2701 to 2719 of 4550 messages
Chat Pages: Latest  110  109  108  107  106  105  104  103  102  101  100  99  Older
DateSubjectAuthorDiscuss
05/3/2019
07:40
I will be going to the event below and have already registered.


05 March 2019

Microsaic Systems plc

("Microsaic" or the "Company")

Investor Event

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments announces that it will be hosting an investor event on 11 March 2019.

The event will be held at Davy's at Woolgate Bar and Brasserie, 25 Basinghall St, London EC2V 5HA from 5.30pm and will take the form of a Company presentation to discuss the annual results followed by a Q&A session, finishing at 8.00pm.

The event is primarily aimed at the private client broker and retail investor communities.

Investors and shareholders who wish to attend the event should register their interest by visiting the link below:

nobbygnome
04/3/2019
11:05
Hoping to multi bag on these, STX,AOR,INFA &GAN all being held for a few years.
ny boy
01/3/2019
09:05
Agree parsons4

Still an illiquid share at this stage, just buy and forget about for some years imo
Dyor as usual GL

ny boy
01/3/2019
07:35
Still here and happy, a lot of posters don't know what "long term" means. It is long term holdings that can get 10 baggers. It is very hard to keep holding a share that has already tripled. This one is at the very beginning IMHO
parsons4
28/2/2019
16:26
Hopefully the nutters won’t arrive to spoil this thread, many investors here are taking a long term view with this Company, so not a place for short term merchants, the spread is often too wide for those types of traders. Buy and hold long term imo

GLA genuine holders.

ny boy
28/2/2019
16:15
Just thin volumes, this stock is a long term hold, follow the specialist institution that holds a large stake at 1.4p + It got too cheap at 1p, most of us are accumulating or a 5-10 year hold, pines you sound stressed, have a cup of tea and a jammy dodger and relax. Are you invested here or just missed the lows and become a bit anxious?

Can’t really pump and dump illiquid stocks, it’s not worth the effort,you must be imagining things.

ny boy
28/2/2019
15:30
L2 strong, looks like some buys are coming in here, not surprised as it got sold off last time after good news, on very little volume, bear trap!
ny boy
28/2/2019
12:57
Approximately eight out of the top ten selling drugs by revenue are biologics and the demand for biologic drugs is estimated to reach revenues of approximately $445 billion in 2019.

The rate of biologic production line installations represents a significant investment for this sector, and the Directors believe that the total market for bioprocessing equipment is currently in the region of $15 billion.

Consequently, the Board believes that the Company's highly differentiated technology represents a strong opportunity for its point of need MS detectors, with the potential to drive substantial revenues from new customers with global reach.

ny boy
28/2/2019
12:49
I would hope so, this is supposed to be a breakthrough year for them according to their last report, let’s see but at 1p, I would hope for 20/30% upside,on the lead up to 12 March, some buying has already started this morning.

The specialist fund that holds a large stake @ 1.4p from last summer, is still there, having read about them, they take stakes to hold for many years, this provides me with a degree of comfort, as they obviously have much better knowledge to carry out extensive due diligence that me here, so let’s see what happens this year. GL

ny boy
28/2/2019
12:41
Yes thanks are you expecting anything positive from them?
barnes4
28/2/2019
11:03
Results Monday 11 March 2019
ny boy
18/2/2019
18:05
Parsons

What’s your take on this one?

Tia

barnes4
15/2/2019
20:42
Thanks yes worked it out

News soon I hope?

Director pays 2p share price 1p

Good gamble imo 20-40 % upside possible in short order

risk1
15/2/2019
18:46
Cash burn > c 3m pa
longstaycarpark5
15/2/2019
12:41
Risk,

Look at the previous trading updates and it tells you how much cash is in the bank. You should be able to work out the cash burn.

k1ngkonggb
15/2/2019
12:13
Cash burn anyone???
risk1
15/2/2019
11:59
Keep focused here, ignore the noise, buy/add when others aren’t, this company is going to have a great few years imo will check back later in the year on progress, but pretty much a steal at 1p area.
ny boy
15/2/2019
11:27
Anyone know what the cash burn is

On the face of it this is quite a compelling situation with all the cash covering the market cap

A small piece of positive news should send this north imo

risk1
15/2/2019
10:29
Check out Dr Biotech comments above. I have asked around about this. There is a relationship between price and performance. Microsaic seems to be middle price low performance.

In others words there may not be a competitive advantage unless miniaturisation a difference and it is not clear, based on sales, that it is.

Question is why would a customer buy this over a rival system with apparently better performance at roughly the same price?

longstaycarpark5
Chat Pages: Latest  110  109  108  107  106  105  104  103  102  101  100  99  Older

Your Recent History

Delayed Upgrade Clock